|
81
|
269
|
3pizA |
Crystal structure of btk kinase domain complexed with (5-amino-1-o-tolyl-1h-pyrazol-4-yl)-[3-(1-methanesulfonyl-piperidin-4-yl)-phenyl]-methanone |
|
81
|
269
|
3pj1A |
Crystal structure of btk kinase domain complexed with 3-(2,6-dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one |
|
83
|
267
|
3pa3A |
X-ray crystal structure of compound 70 bound to human chk1 kinase domain |
|
103
|
348
|
3p78A |
P38 inhibitor-bound |
|
76
|
276
|
3prfA |
Crystal structure of human b-raf kinase domain in complex with a non-oxime furopyridine inhibitor |
|
73
|
271
|
3ppzA |
Crystal structure of ctr1 kinase domain in complex with staurosporine |
|
106
|
348
|
3p7bA |
P38 inhibitor-bound |
|
75
|
276
|
3psbA |
Furo[2,3-c]pyridine-based indanone oximes as potent and selective b-raf inhibitors |
|
109
|
356
|
3pg1A |
Map kinase lmampk10 from leishmania major (1.95 angs resolution) |
|
71
|
254
|
3pdtA |
Crystal structure of the c-terminal truncated alpha-kinase domain of myosin heavy chain kinase |
|
100
|
348
|
3p7cA |
P38 inhibitor-bound |
|
109
|
337
|
3pooA |
Human camp-dependent protein kinase in complex with an inhibitor |
|
84
|
322
|
3pp1A |
Crystal structure of the human mitogen-activated protein kinase kinase 1 (mek 1) in complex with ligand and mgatp |
|
100
|
348
|
3p7aA |
P38 inhibitor-bound |
|
80
|
269
|
3pa5A |
X-ray crystal structure of compound 1 bound to human chk1 kinase domain |
|
74
|
276
|
3priA |
Crystal structure of human b-raf kinase in complex with a non-oxime furopyridine inhibitor |
|
89
|
288
|
3pp0A |
Crystal structure of the kinase domain of human her2 (erbb2). |
|
83
|
267
|
3ot8A |
X-ray crystal structure of compound 17r bound to human chk1 kinase domain |
|
81
|
285
|
3orxA |
Pdk1 mutant bound to allosteric disulfide fragment inhibitor 1f8 |
|
105
|
401
|
3p23A |
Crystal structure of the human kinase and rnase domains in complex with adp |
|
95
|
355
|
3oxiA |
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of jnk for the treatment of neurodegenerative diseases |
|
111
|
328
|
3owjA |
Human ck2 catalytic domain in complex with a pyridocarbazole derivative inhibitor |
|
81
|
267
|
3ot3A |
X-ray crystal structure of compound 22k bound to human chk1 kinase domain |
|
58
|
248
|
3oukA |
Crystal structure of rv3910 from mycobacterium tuberculosis |
|
105
|
350
|
3p4kA |
The third conformation of p38a map kinase observed in phosphorylated p38a and in solution |
|
114
|
325
|
3ofmA |
Structure of a human ck2alpha prime, the paralog isoform of the catalytic subunit of protein kinase ck2 from homo sapiens |
|
88
|
284
|
3oy3A |
Crystal structure of abl t315i mutant kinase domain bound with a dfg-out inhibitor ap24589 |
|
69
|
257
|
3ounB |
Crystal structure of the fhaa fha domain complexed with the intracellular domain of rv3910 |
|
85
|
283
|
3otuA |
Pdk1 mutant bound to allosteric disulfide fragment activator js30 |
|
64
|
276
|
3omvA |
Crystal structure of c-raf (raf-1) |
|
89
|
284
|
3oxzA |
Crystal structure of abl kinase domain bound with a dfg-out inhibitor ap24534 |
|
104
|
330
|
3owlA |
Human ck2 catalytic domain in complex with a benzopyridoindole derivative inhibitor |
|
15
|
149
|
3p5jC |
The structure of the human rnase h2 complex defines key interaction interfaces relevant to enzyme function and human disease |
|
80
|
265
|
3p08A |
Crystal structure of the human btk kinase domain |
|
73
|
272
|
3og7A |
B-raf kinase v600e oncogenic mutant in complex with plx4032 |
|
111
|
336
|
3owpA |
Human camp-dependent protein kinase in complex with an inhibitor |
|
94
|
335
|
3ow4A |
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan akt inhibitors |
|
70
|
254
|
3otvA |
Crystal structure of the intracellular domain of rv3910 from mycobacterium tuberculosis |
|
85
|
289
|
3ortA |
Mycobacterium tuberculosis pknb kinase domain l33d mutant (crystal form 6) |
|
106
|
330
|
3owkA |
Human ck2 catalytic domain in complex with a benzopyridoindole derivative inhibitor |
|
110
|
337
|
3ovvA |
Human camp-dependent protein kinase in complex with an inhibitor |
|
88
|
290
|
3orpA |
Mycobacterium tuberculosis pknb kinase domain l33d mutant (crystal form 5) |
|
106
|
335
|
3oogA |
Human camp-dependent protein kinase in complex with a small fragment |
|
106
|
355
|
3oy1A |
Highly selective c-jun n-terminal kinase (jnk) 2 and 3 inhibitors with in vitro cns-like pharmacokinetic properties |
|
85
|
281
|
3oriA |
Mycobacterium tuberculosis pknb kinase domain l33d mutant (crystal form 1) |
|
86
|
292
|
3orkA |
Mycobacterium tuberculosis pknb kinase domain l33d mutant (crystal form 2) |
|
116
|
378
|
3oz6A |
Crystal structure of mapk from cryptosporidium parvum, cgd2_1960 |
|
110
|
336
|
3ow3A |
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan akt inhibitors |
|
89
|
286
|
3orzA |
Pdk1 mutant bound to allosteric disulfide fragment activator 2a2 |
|
63
|
285
|
3os3A |
Mitogen-activated protein kinase kinase 1 (mek1) in complex with ch4858061 and mgatp |
